DMCC Speciality Chemicals
- P/E
- 15.07
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Standalone · TTM
- ROCE
- 14.80%
- Debt to Equity
- 0.44
- EPS (TTM)
- ₹16.03
- Book Value
- ₹106.28
- Market Cap
- —
- P/E (TTM)
- 15.07
- P/B
- 2.27
- ROE
- 11.50%
- Dividend Yield
- 1.07%
- EBITDA
- ₹64.30 Cr
- 52W High
- ₹374.15
- 52W Low
- ₹191.35
- Day Range
- ₹233.05 – ₹244.20
- Volume
- 56,387
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| DMCC Speciality Chemicals (this company) | ₹241.50 | 15.07 | ₹581 Cr | 2.27 | 1.07% | 11.50% | 14.80% | ₹707 Cr | ₹40 Cr |
| Median 8 companies | ₹1,559.55 | 43.80 | ₹20,474 Cr | 4.68 | 0.36% | 10.66% | 13.35% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 37
- Weak
- Returns, margins, earnings quality 22% weight
- Valuation
- 53
- Average
- Cheap vs sector & own history 24% weight
- Growth
- 98
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 37
- Weak
- Solvency, leverage, coverage 9% weight
- Momentum
- 21
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company is expected to give good quarter
- Company has been maintaining a healthy dividend payout of 24.4%
- Company's median sales growth is 23.2% of last 10 years
Weaknesses
2- Stock is trading at 3.43 times its book value
- Company has a low return on equity of 8.33% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 3 | 4 |
| Oscillators | Bullish | 2 | 3 | 4 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Bullish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 32.90
- Neutral
- MACD (12,26,9)
- −16.16
- Bearish
- SMA (50)
- 296.00
- Bearish
- SMA (200)
- 264.71
- Bearish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +18.35% |
|---|---|
| 5Y | +23.82% |
| 3Y | +14.57% |
| 1Y | +35.03% |
| TTM | +49.68% |
Net profit
| 10Y | +8.45% |
|---|---|
| 5Y | −3.93% |
| 3Y | +56.83% |
| 1Y | +22.73% |
| TTM | +42.86% |
Operating cash flow
| 10Y | Turned negative |
|---|---|
| 5Y | Turned negative |
| 3Y | Turned negative |
| 1Y | Turned negative |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −3.99 pp |
|---|---|
| 5Y | −7.18 pp |
| 3Y | +1.52 pp |
| 1Y | −2.41 pp |
| TTM | −2.16 pp |
Revenue by year
| Mar 2017 | ₹175 Cr |
|---|---|
| Mar 2018 | ₹178 Cr |
| Mar 2019 | ₹227 Cr |
| Mar 2020 | ₹188 Cr |
| Mar 2021 | ₹200 Cr |
| Mar 2022 | ₹326 Cr |
| Mar 2023 | ₹387 Cr |
| Mar 2024 | ₹328 Cr |
| Mar 2025 | ₹431 Cr |
| Mar 2026 | ₹582 Cr |
Net profit by year
| Mar 2017 | ₹17.00 Cr |
|---|---|
| Mar 2018 | ₹12.00 Cr |
| Mar 2019 | ₹46.00 Cr |
| Mar 2020 | ₹31.00 Cr |
| Mar 2021 | ₹33.00 Cr |
| Mar 2022 | ₹21.00 Cr |
| Mar 2023 | ₹7.00 Cr |
| Mar 2024 | ₹12.00 Cr |
| Mar 2025 | ₹22.00 Cr |
| Mar 2026 | ₹27.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 86 | 77 | 81 | 84 | 85 | 103 | 118 | 125 | 127 | 126 | 151 | 178 | 253 | 273 |
| Expenses | 75 | 67 | 73 | 77 | 76 | 87 | 100 | 110 | 110 | 112 | 136 | 160 | 218 | 261 |
| Operating Profit | 11 | 10 | 7 | 7 | 9 | 15 | 18 | 15 | 17 | 14 | 15 | 18 | 35 | — |
| OPM % | 13% | 12% | 9% | 9% | 10% | 15% | 15% | 12% | 13% | 11% | 10% | 10% | 14% | — |
| Other Income | 1 | 1 | 1 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 4 |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | — |
| PBT | 5 | 4 | 0 | 9 | 2 | 9 | 11 | 9 | 11 | 8 | 9 | 11 | 27 | 4 |
| Tax % | 35% | 34% | 6% | 32% | 26% | 32% | 31% | 31% | 30% | 31% | 30% | 29% | 25% | 19% |
| Net Profit | 3 | 2 | 0 | 6 | 1 | 6 | 8 | 6 | 8 | 6 | 6 | 8 | 20 | 3 |
| EPS (₹) | 1.26 | 0.95 | 0.12 | 2.32 | 0.56 | 2.33 | 3.16 | 2.59 | 3.11 | 2.31 | 2.47 | 3.07 | 8.18 | — |
Sep 2026: from the results filed on 30 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 120 | 108 | 175 | 178 | 227 | 188 | 200 | 326 | 387 | 328 | 431 | 582 | 707 |
| Expenses | 101 | 91 | 145 | 155 | 174 | 160 | 165 | 286 | 351 | 292 | 374 | 518 | 626 |
| Operating Profit | 20 | 16 | 30 | 23 | 53 | 28 | 36 | 41 | 36 | 36 | 57 | 63 | 81 |
| OPM % | 16% | 15% | 17% | 13% | 24% | 15% | 18% | 12% | 9% | 11% | 13% | 11% | 12% |
| Other Income | −1 | 0 | 1 | 1 | 1 | 6 | 8 | 6 | 3 | 10 | 1 | 1 | 1 |
| Interest | 2 | 1 | 5 | 4 | 3 | 2 | 2 | 5 | 11 | 14 | 10 | 10 | 11 |
| Depreciation | 2 | 2 | 4 | 4 | 5 | 6 | 7 | 8 | 18 | 16 | 17 | 16 | 16 |
| PBT | 14 | 13 | 21 | 16 | 47 | 26 | 34 | 34 | 10 | 17 | 31 | 39 | 55 |
| Tax % | 0% | 9% | 21% | 21% | 2% | −22% | 4% | 37% | 35% | 33% | 31% | 30% | — |
| Net Profit | 14 | 12 | 17 | 12 | 46 | 31 | 33 | 21 | 7 | 12 | 22 | 27 | 40 |
| EPS (₹) | 6.58 | 5.63 | 7.79 | 4.92 | 18.47 | 12.63 | 13.06 | 8.56 | 2.75 | 4.64 | 8.64 | 10.96 | 16.03 |
| Div. Payout % | 0% | 0% | 0% | 10% | 8% | 0% | 15% | 6% | 0% | 22% | 29% | 23% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 21 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 1 | 13 | 35 | 48 | 91 | 120 | 148 | 168 | 173 | 184 | 202 | 223 |
| Borrowings | 35 | 27 | 30 | 25 | 22 | 25 | 35 | 93 | 101 | 88 | 72 | 110 |
| Other Liabilities | 32 | 34 | 59 | 59 | 51 | 42 | 55 | 97 | 101 | 80 | 81 | 87 |
| Total Liabilities | 88 | 94 | 149 | 156 | 188 | 212 | 263 | 383 | 400 | 377 | 380 | 445 |
| Fixed Assets | 24 | 26 | 83 | 87 | 99 | 101 | 108 | 174 | 230 | 238 | 234 | 219 |
| CWIP | 1 | 5 | 3 | 3 | 1 | 9 | 38 | 63 | 11 | 6 | 0 | 5 |
| Investments | 0 | 0 | 2 | 4 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 2 |
| Other Assets | 63 | 63 | 60 | 62 | 86 | 98 | 116 | 146 | 159 | 132 | 145 | 219 |
| Total Assets | 88 | 94 | 149 | 156 | 188 | 212 | 263 | 383 | 400 | 377 | 380 | 445 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 22 | 17 | 29 | 18 | 21 | 27 | 32 | 51 | 30 | 38 | 38 | −18 |
| Investing | −1 | −7 | −8 | −9 | −13 | −17 | −40 | −98 | −21 | −10 | −7 | −7 |
| Financing | −19 | −10 | −19 | −9 | −8 | −6 | 3 | 45 | −10 | −27 | −30 | 22 |
| Net Cash Flow | 2 | 1 | 2 | 0 | 0 | 5 | −4 | −2 | −1 | 1 | 2 | −2 |
| Free Cash Flow | 21 | 9 | 22 | 10 | 7 | 10 | −10 | −47 | 8 | 19 | 31 | −24 |
| CFO/OP | 113 | 114 | 115 | 94 | 57 | 117 | 100 | 142 | 92 | 111 | 76 | −18 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 44 | 44 | 45 | 45 | 48 | 48 | 58 | 56 | 49 | 51 | 63 | 60 |
| Inventory Days | 62 | 104 | 60 | 73 | 80 | 113 | 151 | 79 | 78 | 81 | 58 | 82 |
| Days Payable | 76 | 115 | 129 | 114 | 79 | 68 | 116 | 131 | 121 | 119 | 84 | 60 |
| Cash Conversion Cycle | 29 | 33 | −25 | 4 | 49 | 93 | 94 | 3 | 6 | 13 | 37 | 83 |
| Working Capital Days | 1 | −7 | −37 | −6 | 43 | 80 | 32 | −5 | 2 | 5 | 16 | 34 |
| ROCE % | 34% | 24% | 35% | 21% | 43% | 18% | 19% | 16% | 7% | 8% | 14% | 15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view DMCC Speciality Chemicals insights
62 extracted metrics across FY11–FY27.
Documents
- Q4 FY26 concall · May 2026Transcript Recording
- Q2 FY26 concall · Nov 2025Transcript
- Q4 FY25 concall · May 2025Transcript PPT
- Q2 FY25 concall · Nov 2024Transcript Recording
- Q4 FY24 concall · May 2024Transcript PPT
- 15 May 2026
- 11 Nov 2025
- 4 May 2026
- 5 May 2025
- 3 Sep 2024
- 4 Sep 2023
- 7 Dec 2022
- General announcements 31 Oct 2026
Frequently Asked Questions about DMCC Speciality Chemicals
What does DMCC Speciality Chemicals Ltd do?
Where is DMCC Speciality Chemicals Ltd (DMCC) listed?
Which sector does DMCC Speciality Chemicals Ltd belong to?
What is the PE ratio of DMCC Speciality Chemicals Ltd?
What is the 52-week high and low of DMCC Speciality Chemicals Ltd?
Does DMCC Speciality Chemicals Ltd pay dividends?
What is the Return on Equity (ROE) of DMCC Speciality Chemicals Ltd?
Company Information
Incorporated in 1919, DMCC Speciality Chemicals Ltd manufactures and sells Commodity and Speciality Chemicals
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/DMCC.md for DMCC Speciality Chemicals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.